ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,847Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 2888

$1.81M Total Retail Price of All Prescriptions

Rank: 39 out of 2888

1,193 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,193 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

24% of this provider’s 1,193 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 20,707 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,349 805 S3 1 4
LEVOTHYROXINE SODIUM 929 702 2 1
FUROSEMIDE 895 702 3 6
LISINOPRIL 767 592 4 3
SIMVASTATIN 760 605 5 2
AMLODIPINE BESYLATE 723 613 6 5
POTASSIUM CHLORIDE 705 508 7 14
GABAPENTIN 704 526 8 13
METOPROLOL SUCCINATE 641 525 9 11
OMEPRAZOLE 572 452 10 7
METFORMIN HCL 457 308 11 8
TRAMADOL HCL 395 271 12 16
QUETIAPINE FUMARATE 387 235 13 66
METOPROLOL TARTRATE 376 292 14 10
CITALOPRAM HBR 364 298 15 24
MIRTAZAPINE 336 308 16 54
WARFARIN SODIUM 328 265 17 22
CARVEDILOL 318 257 18 21
DIGOXIN 316 259 19 55
GLIMEPIRIDE 315 243 20 36
DONEPEZIL HCL 308 296 21 26
LOSARTAN POTASSIUM 301 245 22 18
CYMBALTA 286 144 23 44
NAMENDA 284 271 24 34
ZOLPIDEM TARTRATE 266 185 25 17
NEXIUM 264 173 26 19
PREDNISONE 253 218 27 42
LANTUS 252 125 28 45
MELOXICAM 251 176 29 31
ISOSORBIDE MONONITRATE ER 246 200 30 51
PRAVASTATIN SODIUM 243 161 31 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 216 141 32 28
CRESTOR 213 156 33 20
RANITIDINE HCL 204 160 34 56
SEROQUEL 200 147 35 143
ATORVASTATIN CALCIUM 190 140 36 9
CLONIDINE HCL 186 136 37 39
FLUTICASONE PROPIONATE 183 142 38 32
PANTOPRAZOLE SODIUM 183 123 38 33
NIFEDIPINE ER 182 149 40 76
CARISOPRODOL 182 45 R 40 82
ALLOPURINOL 180 152 42 37
SPIRIVA 177 120 43 79
AZITHROMYCIN 176 112 44 38
SERTRALINE HCL 174 102 45 27
PROMETHAZINE HCL 160 80 R 46 96
CLOPIDOGREL 159 115 47 30
TAMSULOSIN HCL 157 139 48 29
ATENOLOL 156 130 49 25
TRAZODONE HCL 149 87 50 43
ADVAIR DISKUS 144 92 51 60
DIOVAN 141 118 52 35
BUSPIRONE HCL 141 65 52 148
TORSEMIDE 138 110 54 158
BUMETANIDE 137 113 55 203
LOSARTAN-HYDROCHLOROTHIAZIDE 137 115 55 46
ESCITALOPRAM OXALATE 136 92 57 62
INSULIN SYRINGE 134 93 58 86
CYCLOBENZAPRINE HCL 132 70 R 59 68
SPIRONOLACTONE 130 105 60 70
HYDROCHLOROTHIAZIDE 125 91 61 15
PHENYTOIN SODIUM EXTENDED 117 52 62 128
CARBIDOPA-LEVODOPA 117 117 62 113
METHYLPREDNISOLONE 114 82 64 101
KLOR-CON M20 111 105 65 90
HYDRALAZINE HCL 107 95 66 59
AMITRIPTYLINE HCL 102 61 R 67 74
VENLAFAXINE HCL ER 102 64 67 120
CIPROFLOXACIN HCL 101 72 69 47
ZETIA 101 93 69 81
DICYCLOMINE HCL 100 65 71 224
LYRICA 93 19 72 69
POLYETHYLENE GLYCOL 3350 93 70 72 93
AMIODARONE HCL 93 82 72 167
CEFDINIR 91 63 75 194
PLAVIX 91 54 75 40
RAMIPRIL 88 78 77 73
DOXAZOSIN MESYLATE 87 72 78 94
RISPERIDONE 85 67 79 72
AMLODIPINE BESYLATE-BENAZEPRIL 85 67 79 67
METHOCARBAMOL 85 20 R 79 176
LIPITOR 84 35 82 78
LANTUS SOLOSTAR 82 58 83 92
FENTANYL 81 57 S2 84 126
LEVOFLOXACIN 78 58 85 57
ALENDRONATE SODIUM 77 56 86 23
METOCLOPRAMIDE HCL 77 57 86 116
METFORMIN HCL ER 74 59 88 53
NAPROXEN 74 33 88 80
OLANZAPINE 73 59 90 137
BACLOFEN 72 35 91 121
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 48 92 88
BENZTROPINE MESYLATE 69 44 R 93 191
DOXYCYCLINE HYCLATE 69 46 93 123
DILTIAZEM 24HR CD 68 48 95 146
ACETAMINOPHEN-CODEINE 68 40 S3 95 147
VENLAFAXINE HCL 67 37 97 246
BENAZEPRIL HCL 67 51 97 77
TIZANIDINE HCL 66 19 99 133
SINGULAIR 64 33 100 85
HUMALOG 64 59 100 166
FLUOXETINE HCL 63 29 102 83
NIASPAN 62 25 103 127
KLOR-CON M10 62 60 103 118
CLOZAPINE 62 17 103 367
CELEBREX 62 51 103 89
IMIPRAMINE HCL 62 62 R 103 451
PEN NEEDLE 61 44 108 110
FINASTERIDE 57 41 109 102
SYNTHROID 57 57 109 52
BUPROPION HCL SR 57 0 109 231
LACTULOSE 57 48 109 111
DIVALPROEX SODIUM 57 34 109 100
TRICOR 57 28 109 91
PRAMIPEXOLE DIHYDROCHLORIDE 57 29 109 202
OXYBUTYNIN CHLORIDE 57 53 109 124
METRONIDAZOLE 56 43 117 256
FAMOTIDINE 55 23 118 75
TOPIRAMATE 55 0 118 206
DIOVAN HCT 55 25 118 61
IBUPROFEN 54 41 121 87
NITROSTAT 53 40 122 240
DOXEPIN HCL 51 22 123 248
MORPHINE SULFATE ER 51 29 S2 123 229
NOVOLOG 50 27 125 114
AMOXICILLIN 50 35 125 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.